Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Trisomy. Data from NIH RePORTER, last 36 months.
Trisomy has a robust NIH research funding landscape with 88 funded grants and $102.9M in total funding over the period.
22 new grants started in the last 12 months.
6 additional grants classified as “Other” (multi-disciplinary, infrastructure, etc.).
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Trisomy. Strongest funded area: Basic Science. Largest gap: Translational / Drug Development.
5 funded grants in Translational / Drug Development but only 2 related publications found for trisomy. This may indicate early-stage research that hasn't yet produced published results.
These grants mention Trisomy as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.